Verition Fund Management’s GSK GSK Stock Holding History

Verition Fund Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$850K	Buy	15,400 +4,400	+40%	+$238K	0.01%	1379
2025 Q4	$539K	Sell	11,000 -2,600	-19%	-$121K	﹤0.01%	2596
2025 Q3	$587K	Sell	13,600 -1,300	-9%	-$50.8K	﹤0.01%	2930
2025 Q2	$572K	Buy	14,900 +5,200	+54%	+$199K	﹤0.01%	2855
2025 Q1	$376K	Sell	9,700 -15,500	-62%	-$567K	﹤0.01%	2748
2024 Q4	$852K	Hold	25,200	–	–	﹤0.01%	2157
2024 Q3	$1.03M	Buy	25,200 +200	+0.8%	+$8.18K	0.01%	1869
2024 Q2	$963K	Hold	25,000	–	–	0.01%	1699
2024 Q1	$1.07M	Buy	+25,000	New	+$1.03M	0.01%	1584
2023 Q1	–	Sell	-8,200	Closed	-$288K	–	2312
2022 Q4	$288K	Sell	8,200 -43,300	-84%	-$1.44M	﹤0.01%	1535
2022 Q3	$1.52M	Buy	+51,500	New	+$1.95M	0.02%	1096
2022 Q2	–	Sell	-10,160	Closed	-$553K	–	2632
2022 Q1	$553K	Buy	+10,160	New	+$552K	0.01%	1847

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Verition Fund Management's GSK Position: Q1 2026 in Review

Verition Fund Management reduced its GSK (GSK) stake by 16% in Q1 2026, selling an estimated $435K and leaving 41,337 shares worth $2.28M. The position accounts for 0.01% of the portfolio, ranked #946.

Verition Fund Management first reported a position in GSK in Q2 2013 and has held it in 20 quarters since. The position peaked at $23.4M in Q4 2019. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Verition Fund Management held 41,337 shares of GSK worth $2.28M as of Q1 2026.
Verition Fund Management sold 8,031 GSK shares in Q1 2026, an estimated $435K.
GSK made up 0.01% of Verition Fund Management's portfolio in Q1 2026, its #946 holding.
Verition Fund Management first reported a position in GSK in Q2 2013 and has held it in 20 quarters since.
Verition Fund Management's GSK position peaked at $23.4M in Q4 2019.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.